Boron Trichloride → 3-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-ethynylpyrimidin-2-yl)benzene sulfonamide
Reaction equation
B(Cl)(Cl)Cl.C([NH:9][S:10]([C:13]1[CH:18]=[CH:17][CH:16]=[C:15]([C:19]2[N:24]=[C:23]([NH:25][C:26]3[NH:30][N:29]=[C:28]([CH:31]4[CH2:33][CH2:32]4)[CH:27]=3)[C:22]([C:34]#[CH:35])=[CH:21][N:20]=2)[CH:14]=1)(=[O:12])=[O:11])(C)(C)C>C(Cl)Cl>[CH:31]1([C:28]2[NH:29][N:30]=[C:26]([NH:25][C:23]3[C:22]([C:34]#[CH:35])=[CH:21][N:20]=[C:19]([C:15]4[CH:14]=[C:13]([S:10]([NH2:9])(=[O:11])=[O:12])[CH:18]=[CH:17][CH:16]=4)[N:24]=3)[CH:27]=2)[CH2:33][CH2:32]1Participants
Procedure
BCl3 (1 M in CH2Cl2, 0.92 mL, 0.92 mmol, 5 equiv.) was added to a stirred solution of N-tert-butyl-3-(4-(3-cyclopropyl-1H-pyrazol-5-ylamino)-5-ethynylpyrimidin-2-yl)benzenesulfonamide (80 mg, 0.18 mmol, 1.0 equiv.) in CH2Cl2 (20 mL) at room temperature under nitrogen. The reaction mixture was stirred for 30 min and quenched with aq. NaHCO3 under an ice bath. The reaction mixture was extracted with ethylacetate and washed with water, brine, dried, filtered and evaporated. The crude product was crystallized with THF/isopropyl to afford the title compound 3-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-ethynylpyrimidin-2-yl)benzene sulfonamide (Compound 110) (40 mg, 57%). LC-MS (m/z)=380.9 [M+H]+. 1H NMR (400 MHz, DMSO-d6): δ 0.82 (m, 2H), 0.96-0.98 (m, 2H), 1.94 (m, 1H), 4.90 (s, 1H), 6.47 (s, 1H), 7.45 (s, 2H), 7.74 (t, J=8.0 Hz, 1H), 7.97 (d, J=7.6 Hz, 1H), 8.49 (d, J=8.0 Hz, 1H), 8.62 (s, 1H), 8.70 (s, 1H), 8.82 (s, 1H), 12.31 (s, 1H).
Workup
- customquenched with aq. NaHCO3 under an ice bath
- extractionThe reaction mixture was extracted with ethylacetate
- washwashed with water, brine
- customdried
- filtrationfiltered
- customevaporated
- customThe crude product was crystallized with THF/isopropyl
Sources & evidence
- ORD record
- ord-ce59e6a878f04cf1946a40e6a5c24581
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09422271B2
Reaction notes
Loading…